CTRI/2011/11/002175已完成2 期
Evaluation of Ikshvadi Avaleha as an Adjuvant therapy on Rajyakshma w.s.r. to Tuberculosis in Children.
Director0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age group 1 to 16 yrs
- •Classical symptoms of Rajyakshma to emphasis symptoms of Tuberculosis in children like Kasa (Coughing) Anstapa (Pain in shoulder)Vaisvaryam (Horseness of Voice)Jwara (Pyrexia) Parshvaruja (Thorax pain)Shiroruja (Headache)Sonitchhardi (Haematemesis) Shleshmanamchhardi
- •(Productive Cough) Shvasa (Dyspnoea) Kosthamaya (Abdominal disease) Aruchi (Anorexia)
- •The patients of Pulmonary & Extra Pulmonary Tuberculosis under Category 1 and Category 2
排除标准
- •Complicated cases of Tuberculosis.
- •HIV/ AIDS positive cases of Tuberculosis.
- •Seriously ill patients and those who suffered either hepatic injury or hepatitis in the last six months.
研究者
相似试验
尚未招募
2 期
comparative trial of two ayurvedic treatment in improving thyroid profile.CTRI/2020/02/023257CH BRAHM PRAKASH AYURVEDIC CHARAK SANSTHA
尚未招募
2 期
isha Amalaki Vati in uncontrolled type II Diabetes Mellitus.CTRI/2023/04/051473datta meghe institute of higher studies and research
尚未招募
不适用
To Study the effect of Nisha-amalaki as an adjuvant drug in uncontrolled Type II Diabetes mellitusCTRI/2020/12/029806Mahatma Gandhi Ayurved College Hospital and Research Center
尚未招募
不适用
Role of immune boosting kit in covid diseaseCTRI/2020/07/026670All India Institute of Ayurveda
已完成
2 期
Evaluation of Adjuvant Effect of Ayurvedic Medicine in Oxygen Dependant COVID 19 PatientsCTRI/2021/05/033899Parul Institute of Ayurved63